NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.6800
-0.0280 (-3.95%)
Feb 20, 2026, 4:00 PM EST - Market closed

NMTC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
11.7212.13.453.412.120.24
Revenue Growth (YoY)
103.78%250.35%1.33%60.73%772.60%-87.39%
Cost of Revenue
9.138.947.448.445.174.2
Gross Profit
2.583.16-3.99-5.03-3.05-3.96
Selling, General & Admin
7.237.387.96.936.986.26
Operating Expenses
10.237.387.96.936.986.26
Operating Income
-7.64-4.23-11.89-11.96-10.03-10.22
Interest Expense
--0.2-0.1---0
Interest & Investment Income
0.06--0.2--
Other Non Operating Income (Expenses)
0.830.82-0.33-0.070.03-0.01
EBT Excluding Unusual Items
-6.76-3.61-12.32-11.83-10-10.23
Gain (Loss) on Sale of Assets
----0.03--
Legal Settlements
-----0.2
Other Unusual Items
-0.07----0.08
Pretax Income
-6.83-3.61-12.32-11.86-10-9.95
Net Income
-6.83-3.61-12.32-11.86-10-9.95
Net Income to Common
-6.83-3.61-12.32-11.86-10-9.95
Shares Outstanding (Basic)
454027181611
Shares Outstanding (Diluted)
454027181611
Shares Change (YoY)
58.14%50.03%47.69%13.27%49.56%97.52%
EPS (Basic)
-0.15-0.09-0.46-0.65-0.63-0.93
EPS (Diluted)
-0.15-0.09-0.46-0.65-0.63-0.93
Free Cash Flow
-6.26-2.92-11.13-13.27-7.79-8.67
Free Cash Flow Per Share
-0.14-0.07-0.42-0.73-0.49-0.81
Gross Margin
22.03%26.11%-115.42%-147.58%-143.93%-
Operating Margin
-65.25%-34.94%-344.26%-350.84%-473.14%-4205.75%
Profit Margin
-58.28%-29.80%-356.74%-348.03%-471.67%-4094.60%
Free Cash Flow Margin
-53.42%-24.13%-322.39%-389.45%-367.67%-3568.48%
EBITDA
-7.38-3.96-11.64-11.76-9.91-10.14
EBITDA Margin
-63.02%-32.77%----
D&A For EBITDA
0.260.260.250.20.120.08
EBIT
-7.64-4.23-11.89-11.96-10.03-10.22
EBIT Margin
-65.25%-34.94%----
Advertising Expenses
-0.170.110.170.270.34
Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q